Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1997-1-24
|
pubmed:abstractText |
In previous works, we have shown: i) good parameter predictive performances of the USC*PACK Clinical Programs for amikacin therapy in the elderly, ii) no significant difference generally detected between estimated parameter values at days 7 and 14 after the beginning of therapy, iii) assurance of neither accumulation nor toxicity during therapy up to 14 days or more, in our conditions. The objectives of this study were to explore which elements best explained differences found in the pharmacokinetic parameters (PK) of the elderly patients, who had received several courses of amikacin therapy.
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0369-8114
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
44
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
667-74
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8977923-Age Factors,
pubmed-meshheading:8977923-Aged,
pubmed-meshheading:8977923-Aged, 80 and over,
pubmed-meshheading:8977923-Amikacin,
pubmed-meshheading:8977923-Analysis of Variance,
pubmed-meshheading:8977923-Anti-Bacterial Agents,
pubmed-meshheading:8977923-Creatinine,
pubmed-meshheading:8977923-Female,
pubmed-meshheading:8977923-Humans,
pubmed-meshheading:8977923-Male,
pubmed-meshheading:8977923-Metabolic Clearance Rate,
pubmed-meshheading:8977923-Retrospective Studies
|
pubmed:year |
1996
|
pubmed:articleTitle |
[Individual variability of pharmacokinetic parameters of amikacin in the elderly: retrospective studies].
|
pubmed:affiliation |
ADCAPT, Hôpital A.-Charial, Hospices Civils de Lyon 1, Francheville, France.
|
pubmed:publicationType |
Journal Article,
English Abstract
|